Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Artesia, California


Purpose:

The study will evaluate the safety and efficacy of AGN 210669 ophthalmic solution in comparison with AGN 210669 vehicle and bimatoprost ophthalmic solution dosed once-daily each morning, in subjects with ocular hypertension or primary open-angle glaucoma. Subjects will be followed for 2 weeks.


Criteria:

Inclusion Criteria: - Ocular hypertension or primary open-angle glaucoma - Females of non-childbearing potential - Subject requires IOP-lowering therapy in both eyes - IOP ≥ 22 mm Hg and ≤ 34 mm Hg - Has a visual acuity score of 20/100 or better in each eye Exclusion Criteria: - Uncontrolled systemic disease - Active ocular disease - Alteration of existing chronic systemic medications - Known allergy or sensitivity to the study medications - Ophthalmic corticosteroids - Visual field loss which in the opinion of the investigator is functionally significant - History of ocular laser, intraocular surgery, or refractive surgery


NCT ID:

NCT00809848


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Artesia, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.